JYJongjin Yoon

Jongjin Yoon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jongjin Yoon has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Impact of VI-RADS quality score on VI-RADS diagnostic performance for muscle invasion: the role of tumor size and reader experience

    by Yohan Joo, Seong Woo Cho, Justin Ruey Tse, Jongjin Yoon, Dae Chul Jung, Byung Chul Kang, Young Taik Oh, Jae Hyon Park


  • Open Access

    Renal R2* as a noninvasive predictor of hepatorenal syndrome-acute kidney disease in cirrhotic patients with ascites: a retrospective cohort study

    by Jae Hyon Park, Hee Jun Park, Daeun Choi, Jongjin Yoon

    Background: Hepatorenal syndrome-acute kidney disease (HRS-AKD) is associated with poor renal outcomes in cirrhotic patients, yet no established noninvasive imaging marker exists for its early prediction. This study evaluated renal R2* derived from magnetic resonance elastography (MRE) with multi-echo R2* mapping as a noninvasive imaging marker for predicting the development of HRS-AKD in cirrhotic patients with ascites. Methods: This retrospective observational study analyzed 376 patients who underwent liver MRE with multi-echo R2* mapping between January 2018 and October 2024. Median renal R2* values were quantified from the left kidney using radiomics-based analysis. HRS-AKD was defined as an estimated glomerular filtration rate (eGFR) 2 or a ≥50% increase in serum creatinine from baseline within 3 months after MRE, without other causes of renal disease. Diagnostic performance of renal R2* was compared with liver stiffness and serum fibrosis markers, including the aspartate aminotransferase-to-alanine aminotransferase ratio (AAR), aspartate aminotransferase-to-platelet ratio index (APRI), and fibrosis-4 (FIB-4) index. Multivariable logistic regression identified independent predictors of HRS-AKD. Results: Among cirrhotic patients with ascites, 12.9% developed HRS-AKD; 62.5% had a prior episode of HRS-acute kidney injury (AKI). Median renal R2* was higher in patients who developed HRS-AKD (P=0.007), and inversely correlated with eGFR measured at MRE (r=−0.34, P=0.006). Renal R2* did not correlate with serum iron markers or hemoglobin (all P≥0.05). The area under the receiver operating characteristic curve (AUROC) of renal R2* was 74.5 [95% confidence interval (CI): 57.4–91.6] for predicting HRS-AKD, outperforming liver stiffness and serum fibrosis markers. An R2* cut-off of 20.8 s−1 yielded 75% sensitivity and 74% specificity. R2* ≥20.8 s−1 was an independent predictor of HRS-AKD [odds ratio (OR) 16.8; P=0.002]. Conclusions: Renal R2* is a promising noninvasive imaging marker candidate for predicting the development of HRS-AKD in cirrhotic patients with ascites.

  • Open Access

    Efficacy and Safety of Ifosfamide and Mesna in Metastatic Castration-Resistant Prostate Cancer after Taxane-Based Chemotherapy and Novel Hormonal Therapy Failure

    by Chang Gon Kim, Yeo Gyeong Ko, Jongjin Yoon, Chung Lee, Seung Hoon Beom, Young-Deuk Choi, Woong Kyu Han, Won Sik Ham, Hyunho Han, Jongsoo Lee, et al.

    PurposeLimited treatment options exist for patients with metastatic castration-resistant prostate cancer (mCRPC) after the failure of taxane-based chemotherapy and novel hormonal therapy. Here, we report the safety and efficacy of ifosfamide and mesna in patients with mCRPC after the failure of taxane-based chemotherapy and novel hormonal therapy (NCT06236789).Materials and MethodsPatients with histologically confirmed prostate cancer who had failed taxane-based chemotherapy and novel hormonal therapy received ifosfamide 2,500 mg/m2 and mesna 1,500 mg/m2 on days 1–3, repeated every 21 days. Safety, objective response rate, disease control rate, reduction in serum prostate-specific antigen (PSA) concentration by >50% (PSA50) or >90% (PSA90), radiographic progression-free survival (rPFS), and overall survival (OS) were analyzed.ResultsA total of 47 patients with mCRPC were included in the study. The median number of lines of treatment was 5 (range, 3 to 7). All patients were previously administered docetaxel and novel hormonal therapies including abiraterone (51.1%) and/or enzalutamide (61.7%). Thirty-eight patients (80.9%) were administered cabazitaxel. The objective response and disease control rates were 21.3% and 80.9%, respectively. PSA50 and PSA90 were achieved in 31.9% and 10.6%, respectively. During a median follow-up duration of 54.3 months, rPFS and OS were 5.0 and 9.0 months, respectively. All the patients experienced treatment-related adverse events of any grades; however, no new safety signs were detected. Genomic biomarker analysis revealed that alterations in the TP53 pathway were associated with inferior rPFS and OS.ConclusionIfosfamide and mesna showed appreciable efficacy and manageable safety profiles in heavily treated patients with mCRPC.

  • Open Access

    Comparative effects of sevoflurane and desflurane on postoperative renal function in patients with type 2 Diabetes mellitus

    by Jae Hyon Park, Insun Park, Sangun Nah, Chang-Hoon Koo, Yohan Joo, Bon-Wook Koo, Jongjin Yoon

    Background: Although sevoflurane is widely used for general anesthesia, its potential nephrotoxicity remains a concern, particularly in patients with type 2 diabetes mellitus (T2DM). This study compared the renal effects of sevoflurane and desflurane in T2DM patients, focusing on renal cortical fat fraction (RCFF) from preoperative magnetic resonance imaging (MRI). Methods: In this retrospective cohort study, adult T2DM patients who underwent non-cardiac surgery >3 h under sevoflurane or desflurane anesthesia were included if they had preoperative abdominal MRI with proton density fat fraction sequences. The primary outcome was a sustained decline in estimated glomerular filtration rate (eGFR), defined as a ≥ 25% decrease from baseline persisting through postoperative day 7. Propensity score matching (PSM) was performed to minimize confounding, and multivariate logistic regression was used to identify predictors of eGFR decline. Results: A total of 158 patients were analyzed after PSM. Overall, 91/158 (57.6%) experienced a sustained decline in eGFR. The incidence did not differ significantly between groups: 50/79 (63.3%) in the sevoflurane group vs. 41/79 (51.9%) in the desflurane group (p = 0.198). In subgroup analysis, lower preoperative eGFR and RCFF were independent predictors of eGFR decline only in the sevoflurane group. An RCFF threshold of 2% identified increased risk; patients with RCFF p = 0.040), but not under desflurane. Conclusion: T2DM patients with low RCFF (<2%) may be more susceptible to postoperative renal dysfunction following sevoflurane anesthesia. Further studies are needed to confirm this association.

  • Open Access

    Computed tomography-based unsupervised clustering identifies clusters associated with progression free survival in clear cell renal cell carcinoma

    by Jae Hyon Park, Daeun Choi, Chung Lee, Chang Gon Kim, Sangwoo Kim, Minsun Jung, Jongjin Yoon

    Background: This study aimed to develop and validate a radiologic clustering model using CT imaging features to stratify clear cell renal cell carcinoma (ccRCC) patients by prognosis and identify key imaging predictors of 5-year progression free survival (PFS). Methods: This retrospective study included 164 ccRCC patients with multiphase kidney CT and next-generation sequencing (NGS) between September 2003 and October 2024. Qualitative imaging features were extracted, and unsupervised consensus clustering was performed to classify tumors based on radiologic characteristics. A nomogram-based C1 score was derived from features predictive of the high-risk cluster. Model performance was evaluated using C-index and 5-year area under the receiver operating curve (AUC). Genetic alterations and copy number variations (CNVs) were also analyzed for associations with imaging features and survival. Results: Clustering revealed two distinct radiologic subtypes. Cluster C1 characterized by aggressive behavior such as tumor heterogeneity ( p = 0.011), exophytic growth pattern ( p = 0.002), non-smooth margin ( p = 0.019), and renal sinus extension ( p = 0.016), and was independently associated with poorer 5-year PFS ( p = 0.018). The C1 score demonstrated an AUC of 0.992 for predicting cluster C1 in the test-set. Using a cutoff of 0.75, the model achieved 96.3% sensitivity and 96.4% specificity. For predicting 5-year PFS, the C1 score showed moderate performance (AUC 0.65; C-index 0.65), which improved when combined with nodal/distant metastasis and BAP1 mutation status (AUC 0.71; C-index 0.67). Conclusions: Radiologic clustering using CT features enables non-invasive prognostic stratification of ccRCC. The C1 score derived from this approach may serve as a practical tool to guide surveillance and treatment decisions. Trial registration: Retrospectively registered.

  • Open Access

    Prospective Evaluation of Various Ultrasound Parameters for Assessing Renal Allograft Rejection Subtypes: Elasticity and Dispersion as Diagnostic Tools

    by Yeji Kwon, Jongjin Yoon, Dae Chul Jung, Young Taik Oh, Kyunghwa Han, Minsun Jung, Byung Chul Kang

    Kwon Y, et al. Yonsei Med J. 2025 Jan;66:e24. https://doi.org/10.3349/ymj.2024.0082


  • Tumor necrosis in magnetic resonance imaging predicts urothelial carcinoma with squamous differentiation in muscle-invasive bladder carcinoma

    by Jae Hyon Park, Milim Kim, Jongjin Yoon, Insun Park, Dae Chul Jung, Byung-Chul Kang, Young Taik Oh

    Purpose This study investigated radiologic features on preoperative MRI to differentiate urothelial carcinoma with squamous differentiation (UCSD) from conventional urothelial carcinoma (UC) in muscle-invasive bladder carcinoma. Methods Ninety-nine patients who underwent radical cystectomy and a preoperative bladder MRI scan within three months before surgery were retrospectively enrolled. Various MRI features, including tumor length, location, multiplicity, long-to-short axis ratio, morphology, radiologic stage, and degree of severe necrosis, were analyzed. Univariable and multivariable logistic regression analyses were performed to identify MRI features predictive of UCSD. The diagnostic performance of a significant MRI feature was assessed using 5-fold cross-validation. Results Among the MRI features, significant radiologic findings associated with UCSD in the univariable analysis included heterogeneous tumor signal intensity in T2-weighted images (odds ratio [OR], 3.365; 95% confidence interval [CI], 1.213–9.986; P = 0.022) and contrast-enhanced T1-weighted images (OR, 4.428; 95% CI, 1.519–12.730; P = 0.007), as well as marked (≥ 50%) severe necrosis (OR, 17.100; 95% CI, 4.699–73.563; P < 0.001). In the multivariable analysis, marked (≥ 50%) severe necrosis (odds ratio [OR], 13.755; 95% confidence interval [CI], 2.796–89.118; P = 0.004) was a significant predictor of UCSD. Marked (≥ 50%) severe necrosis showed a high specificity of 95.0% with a precision of 65.0% for diagnosing UCSD based on 5-fold cross-validation. Conclusion Preoperative bladder MRI revealing marked severe necrosis may be indicative of UCSD and can assist in distinguishing it from conventional UC.


  • Peripheral zone thickness in preoperative MRI is predictive of Trifecta achievement after Holmium laser enucleation of the prostate (HoLEP).

    by Jae Hyon Park, Jongjin Yoon, Insun Park, Jun Gu Kang, Jongsoo Lee, Jang Hwan Kim, Dae Chul Jung, Byung-Chul Kang, Young Taik Oh

    Purpose To investigate various anatomical features of the prostate using preoperative MRI and patients’ clinical factors to identify predictors of successful Holmium:YAG laser enucleation of the prostate (HoLEP). Methods 71 patients who had received HoLEP and undergone a 3.0-T prostate MRI scan within 6 months before surgery were retrospectively enrolled. MRI features (e.g., total prostate and transitional zone volume, peripheral zone thickness [PZT], BPH patterns, prostatic urethral angle, intravesical prostatic protrusion, etc.) and clinical data (e.g., age, body mass index, surgical technique, etc.) were analyzed using univariable and multivariable logistic regression to identify predictors of successful HoLEP. Successful HoLEP was defined as achieving the Trifecta, characterized by the contemporary absence of postoperative complications within 3 months, a 3-month postoperative maximum flow rate (Qmax) > 15 mL/s, and no urinary incontinence at 3 months postoperatively. Results Trifecta achievement at 3 months post-surgery was observed in 37 (52%) patients. Patients with Trifecta achievement exhibited a lower preoperative IPSS-quality of life score (QoL) (4.1 vs. 4.5, P = 0.016) and a thinner preoperative peripheral zone thickness (PZT) on MRI (7.9 vs.10.3 mm, P < 0.001). In the multivariable regression analysis, a preoperative IPSS-QoL score < 5 (OR 3.98; 95% CI, 1.21–13.07; P = 0.017) and PZT < 9 mm (OR 11.51; 95% CI, 3.51–37.74; P < 0.001) were significant predictors of Trifecta achievement after HoLEP. Conclusions Alongside the preoperative QoL score, PZT measurement in prostate MRI can serve as an objective predictor of successful HoLEP. Our results underscore an additional utility of prostate MRI beyond its role in excluding concurrent prostate cancer.


  • Open Access

    Machine learning model of facial expression outperforms models using analgesia nociception index and vital signs to predict postoperative pain intensity: a pilot study

    by Insun Park, Jae Hyon Park, Jongjin Yoon, Hyo-Seok Na, Ah-Young Oh, Jung-Hee Ryu, Bon-Wook Koo

    Background: Few studies have evaluated the use of automated artificial intelligence (AI)-based pain recognition in postoperative settings or the correlation with pain intensity. In this study, various machine learning (ML)-based models using facial expressions, the analgesia nociception index (ANI), and vital signs were developed to predict postoperative pain intensity, and their performances for predicting severe postoperative pain were compared.Methods: In total, 155 facial expressions from patients who underwent gastrectomy were recorded postoperatively; one blinded anesthesiologist simultaneously recorded the ANI score, vital signs, and patient self-assessed pain intensity based on the 11-point numerical rating scale (NRS). The ML models’ area under the receiver operating characteristic curves (AUROCs) were calculated and compared using DeLong’s test.Results: ML models were constructed using facial expressions, ANI, vital signs, and different combinations of the three datasets. The ML model constructed using facial expressions best predicted an NRS ≥ 7 (AUROC 0.93) followed by the ML model combining facial expressions and vital signs (AUROC 0.84) in the test-set. ML models constructed using combined physiological signals (vital signs, ANI) performed better than models based on individual parameters for predicting NRS ≥ 7, although the AUROCs were inferior to those of the ML model based on facial expressions (all P < 0.050). Among these parameters, absolute and relative ANI had the worst AUROCs (0.69 and 0.68, respectively) for predicting NRS ≥ 7.Conclusions: The ML model constructed using facial expressions best predicted severe postoperative pain (NRS ≥ 7) and outperformed models constructed from physiological signals.


  • Artificial intelligence model predicting postoperative pain using facial expressions: a pilot study

    by Insun Park, Jae Hyon Park, Jongjin Yoon, In-Ae Song, Hyo-Seok Na, Jung-Hee Ryu, Ah-Young Oh

    Purpose This study aimed to assess whether an artificial intelligence model based on facial expressions can accurately predict significant postoperative pain. Methods A total of 155 facial expressions from patients who underwent gastric cancer surgery were analyzed to extract facial action units (AUs), gaze, landmarks, and positions. These features were used to construct various machine learning (ML) models, designed to predict significant postoperative pain intensity (NRS ≥ 7) from less significant pain (NRS < 7). Significant AUs predictive of NRS ≥ 7 were determined and compared to AUs known to be associated with pain in awake patients. The area under the receiver operating characteristic curves (AUROCs) of the ML models was calculated and compared using DeLong’s test. Results AU17 (chin raising) and AU20 (lip stretching) were found to be associated with NRS ≥ 7 (both P ≤ 0.004). AUs known to be associated with pain in awake patients did not show an association with pain in postoperative patients. An ML model based on AU17 and AU20 demonstrated an AUROC of 0.62 for NRS ≥ 7, which was inferior to a model based on all AUs (AUROC = 0.81, P = 0.006). Among facial features, head position and facial landmarks proved to be better predictors of NRS ≥ 7 (AUROC, 0.85–0.96) than AUs. A merged ML model that utilized gaze and eye landmarks, as well as head position and facial landmarks, exhibited the best performance (AUROC, 0.90) in predicting significant postoperative pain. Conclusion ML models using facial expressions can accurately predict the presence of significant postoperative pain and have the potential to screen patients in need of rescue analgesia. Trial registration number This study was registered at ClinicalTrials.gov (NCT05477303; date: June 17, 2022).